Belgium Supplementary Protection Certificates
✉ Email this page to a colleague
Supplementary Protection Certificates in Belgium
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2506716 | 2020C/505 | Belgium | PRODUCT NAME: UPADACITINIB OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: EU/1/19/1404 20191218 | ⤷ Try a Trial |
European Patent Office | 1578771 | 2014C/004 | Belgium | PRODUCT NAME: LIPEGLIFGRASTIM; AUTHORISATION NUMBER AND DATE: EU/1/13/856 20130725 | ⤷ Try a Trial |
European Patent Office | 1355673 | 2012C/050 | Belgium | PRODUCT NAME: OLIGOSACCHARIDE MENINGOCOCCIQUE DU GROUPE A, C, W135 ET Y CONJUGUE A LA PROTEINE CRM197 DE CORYNEBACTERIUM DIPHTHERIAE; AUTHORISATION NUMBER AND DATE: EU/1/10/614/001 20100317 | ⤷ Try a Trial |
European Patent Office | 2445911 | 2021C/508 | Belgium | PRODUCT NAME: FILGOTINIB OU UN SEL DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/20/1480 20200925 | ⤷ Try a Trial |
European Patent Office | 2215124 | 2016C/030 | Belgium | PRODUCT NAME: EVOLOCUMAB; AUTHORISATION NUMBER AND DATE: EU/1/15/1016 20150721 | ⤷ Try a Trial |
European Patent Office | 1335987 | 2013C/065 | Belgium | PRODUCT NAME: VIRUS VIVANT MODIFIE DE LA VACCINE ANKARA; AUTHORISATION NUMBER AND DATE: EU/1/13/855 20130805 | ⤷ Try a Trial |
European Patent Office | 1615945 | 2014C/003 | Belgium | PRODUCT NAME: LIPEGFILGRASTIM; AUTHORISATION NUMBER AND DATE: EU/1/13/856 20130729 | ⤷ Try a Trial |
>Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |